New drug shows synergistic effect with antifungals in killing drug-resistant fungi

FHS
July 10, 2023
11:37 pm

A study conducted at the University of São Paulo (USP) in Brazil shows that brilacidin, a new drug tested for treatment of diseases ranging from bacterial skin infections to COVID-19, can kill drug-resistant strains of fungi when combined with two classes of antifungals available on the market.

Study suggests maternal adverse childhood experiences may become biologically embedded

Researchers investigated the transfer of biological embedding of life experience across generations by evaluating traumatic childhood experiences of mothers and epigenetic clocks in pregnant mothers

August 13, 2024

Bluebird in fundraising mode: A $150M public offering and a deal to get cash early from gene therapy sales

Facing a financial void it had hoped to be filled by a priority review voucher, bluebird bio is tapping two different sources to bring in

December 20, 2023

Amgen’s Leah Christl makes the case to keep the interchangeability designation for biosimilars

Amgen and its portfolio of 11 biosimilars is standing behind interchangeability, saying the designation should not be rescinded and that the FDA needs to retain

September 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.